Severe vitamin D deficiency associated with BRAF-mutated melanoma

被引：4
|
作者：
Fearfield, L. [1 ]
Nobbs, J. [1 ]
Petruckevitch, A. [2 ]
Harland, C. [1 ]
机构：
[1] Royal Marsden Hosp, Dept Dermatol, Skin & Melanoma Unit, London, England
[2] Royal Marsden Hosp, Dept Stat, London, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 181卷 / 06期
关键词：
SURVIVAL;
D O I：
10.1111/bjd.18413
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1343 / 1343
页数：1
相关论文
共 50 条
  • [21] The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
    Vanni, Irene
    Tanda, Enrica Teresa
    Spagnolo, Francesco
    Andreotti, Virginia
    Bruno, William
    Ghiorzo, Paola
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [22] Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients
    Sullivan, Ryan J.
    Hamid, Omid
    Gonzalez, Rene
    Infante, Jeffrey R.
    Patel, Manish R.
    Hodi, F. Stephen
    Lewis, Karl D.
    Tawbi, Hussein A.
    Hernandez, Genevive
    Wongchenko, Matthew J.
    Chang, YiMeng
    Roberts, Louise
    Ballinger, Marcus
    Yan, Yibing
    Cha, Edward
    Hwu, Patrick
    [J]. NATURE MEDICINE, 2019, 25 (06) : 929 - +
  • [23] Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients
    Pier Francesco Ferrucci
    Marko Lens
    Emilia Cocorocchio
    [J]. Current Oncology Reports, 2021, 23
  • [24] Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients
    Ferrucci, Pier Francesco
    Lens, Marko
    Cocorocchio, Emilia
    [J]. CURRENT ONCOLOGY REPORTS, 2021, 23 (12)
  • [25] TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro
    Delyon, Julie
    Vallet, Anais
    Bernard-Cacciarella, Melanie
    Kuzniak, Isabelle
    Reger de Moura, Coralie
    Louveau, Baptiste
    Jouenne, Fanelie
    Mourah, Samia
    Lebbe, Celeste
    Dumaz, Nicolas
    [J]. CANCERS, 2023, 15 (11)
  • [26] Segmental pityriasis rosea within the area of BRAF-mutated metastatic melanoma
    Murad, A.
    Ralph, N.
    Mulligan, N.
    Moloney, F. J.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (11) : E133 - E134
  • [27] Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
    Matthew Holderfield
    Marian M. Deuker
    Frank McCormick
    Martin McMahon
    [J]. Nature Reviews Cancer, 2014, 14 : 455 - 467
  • [28] Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
    Holderfield, Matthew
    Deuker, Marian M.
    McCormick, Frank
    McMahon, Martin
    [J]. NATURE REVIEWS CANCER, 2014, 14 (07) : 455 - 467
  • [29] mTORC2: therapeutic target in resistant BRAF-mutated melanoma
    Ezine, E.
    Lebbe, C.
    Dumaz, N.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S261 - S261
  • [30] Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma
    Curl, Patti
    Vujic, Igor
    van 't Veer, Laura J.
    Ortiz-Urda, Susana
    Kahn, James G.
    [J]. PLOS ONE, 2014, 9 (09):
12345